Top compounds associated with response to CCDC73


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.05 0.2
mRNA LY317615 GDSC1000 pan-cancer AAC -0.049 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.067 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA bendamustine CTRPv2 pan-cancer AAC -0.052 0.2
mRNA XL765 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.045 0.2
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC 0.052 0.2
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.048 0.2
Download CSV